Skip to content
Screener

Intuitive Surgical ISRG Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$300M-44.5%
Microbot Medical logo
Microbot MedicalMBOT
$86.24M+2,945%
Pulmonx Corporation logo
Pulmonx CorporationLUNG
$40K-63.6%
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT
$183K-79.0%
Medtronic logo
MedtronicMDT
$97M-10.2%
Stereotaxis logo
StereotaxisSTXS
$4.85M+15,066%

Other financials

Income statement

See full
Revenue$2.9B+18.5%
Gross profit$2.0B+21.2%
Operating income$971.9M+30.7%
Net income$818.1M+24.3%
EPS (diluted)$2.29+26.5%

Balance sheet

See full
Cash & equivalents$2.8B-18.6%
Total debt$170.9M+17.1%
Total equity$18.2B+1.8%
Total assets$20.9B+3.5%

Cash flow

See full
Operating cash flow$1.1B+48.3%
CapEx$112.6M-27.5%
Free cash flow$948.4M+69.3%

Valuation

See full
Market cap$132.55B-22.0%
P/E42.2×-22.9×
P/S12×-6.6×

Profitability

See full
Gross margin66.7%+0.1pp
Operating margin31.3%+2.5pp
Net margin28.4%-0.1pp
FCF margin29.2%+7.4pp

Returns & leverage

See full
Return on equity17.4%+1.4pp
Debt / equity0.0×
Current ratio-0.2×

Where this comes from

Reported directly by Intuitive Surgical in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.

The source filing: Intuitive Surgical’s 10-K, filed February 3, 2026.

Filed
Feb 3, 2026, 4:59 PM EST
Fiscal year
FY2025
Accession
0001035267-26-000010
Line itemYear Ended December 31, 2025Year Ended December 31, 2024Year Ended December 31, 2023
Acquisition of businesses, net of cash, and intellectual property and other investing activities(13.9)(1.0)(8.9)
Net cash provided by (used in) investing activities665.8(3,272.8)(360.1)
Financing activities:
Proceeds from issuance of common stock relating to employee stock plans350.3429.4296.3
Taxes paid related to net share settlement of equity awards(419.1)(270.0)(164.7)
Repurchases of common stock(2,295.3)(416.3)
Cash dividends paid by joint venture to noncontrolling interest(8.0)
Payment of deferred purchase consideration(0.5)(2.9)

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Intuitive Surgical's stock issuance proceeds?
Intuitive Surgical (ISRG) reported stock issuance proceeds of $76.6M in Q4 2025.
How has Intuitive Surgical's stock issuance proceeds changed year-over-year?
Intuitive Surgical's stock issuance proceeds increased by 23.7% year-over-year, from $61.9M to $76.6M.
What is the long-term trend for Intuitive Surgical's stock issuance proceeds?
Over 4 years (2021 to 2025), Intuitive Surgical's stock issuance proceeds has grown at a 6.1% compound annual growth rate (CAGR), from $276.5M to $350.3M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Ask your AI about Intuitive Surgical's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude